Abstract
Hydrogels' biocompatibility, adjustable characteristics, and capacity for controlled drug release have made them attractive delivery systems for anti-inflammatory drugs. These technologies lessen the drawbacks of traditional medication delivery techniques, namely their low bioavailability and systemic side effects. The development, workings, and developments of hydrogel-based delivery methods specifically designed to reduce inflammation are examined in this paper. It explores the various kinds of hydrogels, their potential for therapeutic use, and the present difficulties in bringing these systems from the lab to the clinic.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Advanced Multidisciplinary Research and Studies
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
